「重要なお知らせ:日本語書籍をご購入いただき、eLibraryをご利用の皆さまへ」
エルゼビアは、より快適にサービスをご利用いただくため、システムの重要なアップデートを実施いたします。
現在eLibraryで日本語電子書籍をご利用のお客様は、今後より高いアクセシビリティとセキュリティを備えた新しいプラットフォーム「eBooks+」へアカウントが2025年11月中旬から下旬に移行されます。
お客様ご自身でのお手続きは不要です。ご利用中のコンテンツはすべて自動的に移行され、移行作業が完了次第、自動的にeBooks+へリダイレクトされます。
The pathogenesis of microvascular complications is complex and multifactorial. Yet, hyperglycemia emerges as the most important single cause, which has been proved by the Diabetes Control and Complications Trial (DCCT). Thus, the importance of protecting the body from hyperglycemia cannot be overstated; the direct and indirect effects on the human vascular tree are the major source of morbidity and mortality in both type 1 and type 2 diabetes. Generally, the injurious effects of hyperglycemia are separated into macrovascular complications (coronary artery disease, peripheral arterial disease, and stroke) and microvascular complications (diabetic nephropathy, neuropathy, and retinopathy). It is important for physicians to understand the relationship between diabetes and vascular disease because the prevalence of diabetes continues to increase in our country, and the clinical requirements for primary and secondary prevention of these complications are also expanding.